Compound Detail
CHEMBL2105712
AFATINIB DIMALEATE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O
Basic Information
| ChEMBL ID | CHEMBL2105712 |
| Name | AFATINIB DIMALEATE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | USNRYVNRPYXCSP-JUGPPOIOSA-N |
| Therapeutic | ✓ Yes |
| Parent Compound | CHEMBL1173655 |
| Active Moiety | CHEMBL1173655 |
13
Targets
33
Activities
3
Assay Types
0
PK Parameters
20
Publications
9
Known Names
2
Indications
3
Mechanisms
Molecular Properties
485.9
MW (Da)
4.39
ALogP
7
HBA
2
HBD
88.6
PSA (Ų)
0.46
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2013 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Epidermal growth factor receptor erbB1 inhibitor | INHIBITOR | Epidermal growth factor receptor | ✓ | ✓ |
| Receptor protein-tyrosine kinase erbB-2 inhibitor | INHIBITOR | Receptor tyrosine-protein kinase erbB-2 | ✓ | ✓ |
| Receptor protein-tyrosine kinase erbB-4 inhibitor | INHIBITOR | Receptor tyrosine-protein kinase erbB-4 | ✓ | ✓ |
Indications
Carcinoma, Non-Small-Cell Lung Multiple Myeloma
Activity Summary
Kd 21 meas. best 9.52
IC50 10 meas. best 9.4
EC50 2 meas. best 7.89
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4689842 | U2OS | 262 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 262 |
| - | 10.6019/CHEMBL4689842 | HEK-293T | 260 |
| - | 10.6019/CHEMBL5674860 | Colon cancer organoid | 12 |
| - | 10.6019/CHEMBL5724558 | Colon cancer organoid | 12 |
| - | 10.6019/CHEMBL5212743 | Tyrosine-protein kinase ABL1 | 11 |
| - | 10.6019/CHEMBL5608141 | Colon cancer organoid | 6 |
| - | 10.6019/CHEMBL5212743 | Epidermal growth factor receptor | 3 |
| 26310890 | 10.1016/j.ejmech.2015.08.026 | Mus musculus | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 26310890 | 10.1016/j.ejmech.2015.08.026 | NCI-H1975 | 2 |
| - | 10.6019/CHEMBL5212743 | Tyrosine-protein kinase Lck | 2 |
| - | 10.6019/CHEMBL5060014 | Tyrosine-protein kinase ABL1 | 1 |
| - | 10.6019/CHEMBL5724564 | Hepatocyte spheroids | 1 |
| - | 10.6019/CHEMBL5060014 | Glycogen synthase kinase-3 beta | 1 |
| - | 10.6019/CHEMBL5060014 | Peregrin | 1 |
| - | 10.6019/CHEMBL5060014 | Bromodomain-containing protein 4 | 1 |
| - | 10.6019/CHEMBL5060014 | Aurora kinase A | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| 26310890 | 10.1016/j.ejmech.2015.08.026 | NON-PROTEIN TARGET | 1 |
Data from ChEMBL 36 via Core Engine